High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective.
about
Mass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury TreatmentEarly acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionalsUse of steroids for acute spinal cord injury must be reassessed.Antioxidant therapies in traumatic brain and spinal cord injuryBehavioral and Histopathological Study of Changes in Spinal Cord Injured Rats Supplemented with Spirulina platensisMethylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.Non-surgical management of spinal cord injury.The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury.Methylprednisolone for acute spinal cord injury: not a standard of careSelf-assembled rosette nanotubes encapsulate and slowly release dexamethasoneShould this study change my practice?Nanomedicine for treating spinal cord injury.Does early decompression improve neurological outcome of spinal cord injured patients? Appraisal of the literature using a meta-analytical approach.High-dose steroids for acute spinal cord injury in emergency medical services.Fracture dislocations of the cervical spine: a review of 106 conservatively and operatively treated patientsComparative Study on the Effects of Ceftriaxone and Monocytes on Recovery after Spinal Cord Injury in Rat.Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery.Neuroprotection and acute spinal cord injury: a reappraisalCaspase inhibitors as neuroprotective agents.The potential for cellular therapy combined with growth factors in spinal cord injury.Bridging the lesion-engineering a permissive substrate for nerve regenerationHigh dose methylprednisolone in the immediate management of acute, blunt spinal cord injury: what is the current practice in emergency departments, spinal units, and neurosurgical units in the UK?A survey on spinal cord injuries resulting from stabbings: a case series study of 12 years' experience.Role of electrical stimulation for rehabilitation and regeneration after spinal cord injury: an overview.Stem cell-based cell therapy for spinal cord injury.Clinical studies in spinal cord injury: moving towards successful trials.Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury.The paralyzed cat. Neuroanatomic diagnosis and specific spinal cord diseases.Mortality and morbidity after high-dose methylprednisolone treatment in patients with acute cervical spinal cord injury: a propensity-matched analysis using a nationwide administrative database.Transplantation of umbilical cord blood stem cells for treating spinal cord injury.Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages.Ion channel blockers and spinal cord injury.Emergency neurological life support: traumatic spine injury.Designing drugs that encourage spinal cord injury healing.Emergency Neurological Life Support: Traumatic Spine Injury.Practice patterns in the management of acute intervertebral disc herniation in dogs.Longitudinal enlargement of the lesion after spinal cord injury in the rat: a consequence of malignant edema?Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.Efficacy of methylprednisolone therapy for the injured rat spinal cord.High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.
P2860
Q28395356-89A17031-7E15-457A-8400-71521E1223FAQ30440562-E1F2CC8C-97A2-4CE5-915A-EBE388A42616Q33802878-039E675F-BA09-4B0B-B12A-2D6DB1F890C8Q34049949-DE6672A4-26BA-4A90-A6FE-320AB72F5A71Q34054624-85D3C8C2-6181-4441-AE24-0AE0CE478D1EQ34132516-4AEA410E-8A01-47FF-8555-909DD3DCCCDDQ34581480-598661AE-2846-4EE0-AC6D-863589A6F599Q34811137-A3591C4D-BB2B-457B-A089-67EA41B5B540Q34963262-7E725664-7CAB-4E81-9930-BD2DEE9007F8Q35071579-F01DB53F-4D5D-4D16-9F3B-B05EA70C4665Q35117184-30EFD8C5-BBAC-46F4-BBD1-8CA2C6ACB60CQ35216746-605980B9-D1FF-4BAB-9408-B1036A9562FBQ35827838-CC2362BD-9325-4365-B40E-BABFF3921C4AQ35856466-63D74091-DBF7-480F-ABF8-C4B006B61D29Q35858525-CE99C314-CB72-4085-AA9A-B4896801D4F9Q35895236-5CFF110E-0028-4B46-966A-DBCE66AF8E76Q35980880-5E44CFD2-20A8-40F7-B783-6A1EBB6FB7DFQ36045235-4CBBF424-AEDF-40C7-84D8-CADFFF4C0280Q36179653-CFBAABEA-A395-4267-B1DD-3953C26E0885Q36317961-D1338B81-8E47-4F6E-878F-047B9FCCA71FQ36345120-96C2EF80-9FB4-43BA-B59D-A9DB382E6153Q36516005-739D7E76-C478-47F8-876C-42D370A7A36FQ36666587-A3D6D6F0-FCB5-48C8-9B6A-F3097F8FD7C7Q36856898-AE6B2E67-16BB-455A-8752-CC94B1F93A03Q36893915-0832099F-C8BE-4785-8763-8B4F1D6A37B3Q37068830-C063A1DE-A6EA-4364-AD57-5017D6515422Q37425265-5C6625CD-00C8-47F6-8A83-3A396389E15CQ37457522-38DB3353-3340-4202-BB74-D23338D68A4BQ37600056-5B9BA2E7-95A2-4074-855F-FC633C1B91AAQ37763613-6B88BB13-EC49-4F1F-9291-E94F6826770EQ37833644-38357054-8569-44AC-B31B-6AF4C3F325E9Q37851908-804A135D-5EBE-402A-9989-44AB02477B5CQ38042354-4C399A37-FB18-4486-B74D-55A694111796Q38234093-8F13C790-1203-42F8-898E-DFA21391766EQ38599753-12ECE2A2-0B09-4D5E-ADE0-7F9854DC6501Q38858878-7DCC5C35-77BB-4A36-ADB5-F4A477AB3714Q39373885-DEC05B4F-9215-4115-8E52-58BB4482792AQ41091799-DEBC8548-9503-4846-9E53-22739BFAF8B7Q43947429-670BCFF9-944D-4800-8314-88F4D49ECA51Q45144873-831E7E56-0952-4B9A-94B5-E22CCD98BF2A
P2860
High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
High dose methylprednisolone i ...... w from a clinical perspective.
@ast
High dose methylprednisolone i ...... w from a clinical perspective.
@en
type
label
High dose methylprednisolone i ...... w from a clinical perspective.
@ast
High dose methylprednisolone i ...... w from a clinical perspective.
@en
prefLabel
High dose methylprednisolone i ...... w from a clinical perspective.
@ast
High dose methylprednisolone i ...... w from a clinical perspective.
@en
P2093
P356
P1433
P1476
High dose methylprednisolone i ...... w from a clinical perspective.
@en
P2093
P2888
P304
P356
10.1038/SJ.SC.3100986
P577
2000-05-01T00:00:00Z
P5875
P6179
1025469214